The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study

The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study

Abstract To observe the efficacy and safety of Ripertamab in the treatment of Idiopathic Membranous Nephropathy (IMN). Clinical data from patients with IMN treated with Ripertamab or Rituximab were retrospectively collected from six tertiary hospitals in Jilin Province between January and December 2...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyang Li, Yingying Liu, Xueyan Zhu, Hua Jin, Xiaoxuan Zhang, Lei Wang, Yingchun Cui, Feng Xu, Yangwei Wang, Yanyan Song, Wenpeng Cui
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Idiopathic membranous nephropathy
Ripertamab
Rituximab
Efficacy
Safety
Online Access:https://doi.org/10.1038/s41598-025-06046-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-06046-1

Similar Items